A new guideline released Nov. 6 by the ACC, American Heart Association and the Heart Rhythm Society outlines the clinical presentation and approach to clinical evaluation of patients who may have bradycardia or conduction diseases.

The guideline includes recommendations addressing the selection and timing of diagnostic testing tools, as well as available treatment options such as lifestyle interventions, pharmacotherapy and external and implanted devices. Read more on ACC.org.

Visit the Bradycardia and Cardiac Conduction Delay Guideline Hub on ACC.org for resources including a slide set, perspectives, apps and tools, and CardioSmart patient resources. The Bradycardia Guideline Hub on JACC also features tools including the central illustration.